- Home
- RLAY vs VANI Comparison
RLAY vs VANI Comparison
Compare RLAY & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- VANI
- Stock Information
- Founded
- RLAY 2015
- VANI 1998
- Country
- RLAY United States
- VANI United States
- Employees
- RLAY N/A
- VANI N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RLAY Health Care
- VANI Health Care
- Exchange
- RLAY Nasdaq
- VANI Nasdaq
- Market Cap
- RLAY 576.1M
- VANI 75.2M
- IPO Year
- RLAY 2020
- VANI 2014
- Fundamental
- Price
- RLAY $3.60
- VANI $1.40
- Analyst Decision
- RLAY Strong Buy
- VANI Strong Buy
- Analyst Count
- RLAY 11
- VANI 1
- Target Price
- RLAY $18.40
- VANI $4.00
- AVG Volume (30 Days)
- RLAY 1.6M
- VANI 141.6K
- Earning Date
- RLAY 08-05-2025
- VANI 08-12-2025
- Dividend Yield
- RLAY N/A
- VANI N/A
- EPS Growth
- RLAY N/A
- VANI N/A
- EPS
- RLAY N/A
- VANI N/A
- Revenue
- RLAY $7,679,000.00
- VANI N/A
- Revenue This Year
- RLAY $17.59
- VANI N/A
- Revenue Next Year
- RLAY N/A
- VANI N/A
- P/E Ratio
- RLAY N/A
- VANI N/A
- Revenue Growth
- RLAY N/A
- VANI N/A
- 52 Week Low
- RLAY $1.78
- VANI $0.91
- 52 Week High
- RLAY $10.72
- VANI $1.50
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- VANI 74.26
- Support Level
- RLAY $3.50
- VANI $1.26
- Resistance Level
- RLAY $3.86
- VANI $1.30
- Average True Range (ATR)
- RLAY 0.18
- VANI 0.06
- MACD
- RLAY 0.02
- VANI 0.00
- Stochastic Oscillator
- RLAY 65.79
- VANI 69.70
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.